METHOD OF DETERMINING PANCREATIC DISEASE
A method of determining pancreatic disease of the present invention is a method of determining whether an IPMN patient has pancreatic disease, the method including: a first step of measuring a concentration of S100P in duodenal juice of the IPMN patient; and a second step of determining the IPMN pat...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
04.05.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A method of determining pancreatic disease of the present invention is a method of determining whether an IPMN patient has pancreatic disease, the method including: a first step of measuring a concentration of S100P in duodenal juice of the IPMN patient; and a second step of determining the IPMN patient is a malignant IPMN patient or a pancreatic cancer patient when the concentration of the S100P is equal to or greater than a predetermined cutoff value, and the IPMN patient is a benign IPMN patient when the concentration of the S100P is smaller than the predetermined cutoff value. |
---|---|
Bibliography: | Application Number: US201715404861 |